Role of Salivary MicroRNA as a Marker of Progesterone Resistance in Endometriosis: Preliminary Results from a Single-Institution Experience
Biomolecules · 27.03.2025 · 15 (4) · 493
DOI: 10.3390/biom15040493 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 27.03.2025. Verfasst von Matilde Degano und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Obstetrics and Gynecology, Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine…. Hauptthemen laut MEDLINE: Endometriosis, MicroRNAs, Saliva, Progesterone. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This feasibility study explores the potential of salivary microRNAs (miRNAs) as non-invasive biomarkers for diagnosing endometriosis and assessing treatment response. Almost one-third of patients with endometriosis do not respond to the standard progestin treatment due to various mechanisms of progesterone resistance. MiRNAs, recognized for their stability in body fluids and role in gene regulation, may offer new diagnostic and prognostic opportunities as they are involved in the pathogenic pathways of endometriosis and progesterone resistance. We sequenced salivary miRNAs in three cohorts of patients: control women without endometriosis and patients with endometriosis who responded and did not respond to standard progestin treatment. This aims to identify the differential miRNA expression profiles associated with therapeutic response to dienogest. The preliminary results demonstrate the feasibility of miRNA sequencing from saliva and reveal distinct miRNA profiles between responders, non-responders, and controls. Key miRNAs, including mir-3168, the mir-200a family, and mir-93-5p, emerged as potential biomarkers, showing significant differential expression linked to both endometriosis presence and treatment response. Further validation of these findings in larger cohorts could pave the way for miRNA-based diagnostic and prognostic tools, potentially reducing diagnostic delays and personalizing treatment approaches for endometriosis patients, also with new target therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinic of Obstetrics and Gynecology, Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy.
- Institute of Pathology, Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy.
- PhD School in Biomedical Sciences, Gender Medicine, Child and Women Health, University of Sassari, 07100 Sassari, Italy.
- Department of Molecular and Developmental Medicine, Obstetrics and Gynecological Clinic, University of Siena, 53100 Siena, Italy.
- Division of Gynaecology and Human Reproduction Physiopathology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, 40138 Bologna, Italy.
- DMED Department of Medicine, University of Udine, 33100 Udine, Italy.
ORCID-Profile: Silvia Zermano, Stefano Restaino, Martina Arcieri, Errico Zupi, Giuseppe Vizzielli
Zitieren
APA
Degano, M., Vesca, G., Bulfoni, M., Zermano, S., Restaino, S., Arcieri, M., Zupi, E., Seracchioli, R., Driul, L., Cesselli, D., Scambia, G., Biasioli, A., & Vizzielli, G. (2025). Role of Salivary MicroRNA as a Marker of Progesterone Resistance in Endometriosis: Preliminary Results from a Single-Institution Experience. Biomolecules, 15(4), 493. https://doi.org/10.3390/biom15040493
Vancouver
Degano M, Vesca G, Bulfoni M, Zermano S, Restaino S, Arcieri M, et al. Role of Salivary MicroRNA as a Marker of Progesterone Resistance in Endometriosis: Preliminary Results from a Single-Institution Experience. Biomolecules. 2025;15(4):493. doi:10.3390/biom15040493
BibTeX
@article{Degano2025,
author = {Degano, Matilde and Vesca, Giorgia and Bulfoni, Michela and Zermano, Silvia and Restaino, Stefano and Arcieri, Martina and Zupi, Errico and Seracchioli, Renato and Driul, Lorenza and Cesselli, Daniela and Scambia, Giovanni and Biasioli, Anna and Vizzielli, Giuseppe},
title = {Role of Salivary MicroRNA as a Marker of Progesterone Resistance in Endometriosis: Preliminary Results from a Single-Institution Experience},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {4},
pages = {493},
doi = {10.3390/biom15040493}
}
EUVIMED